Zobrazeno 1 - 10
of 37
pro vyhledávání: '"SU-XIA LUO"'
Autor:
Ning Li, Tao Wu, Yong-Gui Hong, Yan-Zhen Guo, Yu-Feng Cheng, Yi-Jie Ma, Liang-Yu Bie, Dong-Hai Cui, Xiao-Hui Gao, Bing-Xu Tan, Bao-Sheng Li, Su-Xia Luo, Jun-Sheng Wang
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Anlotinib, a tyrosine kinase inhibitor, has shown encouraging anti-tumor activity in esophageal squamous cell carcinoma (ESCC). This study was designed to assess the efficacy and safety of anlotinib plus paclitaxel and cisplatin (
Externí odkaz:
https://doaj.org/article/ca63e027c0854a28ac12c5c52b9eebae
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Antibody-based cancer therapeutics is developing rapidly in recent years for its advantages in precisely targeting the tumor cells. However, tumor-specific cell surface antigens are still lacking, and the heterogeneity of tumor mass great
Externí odkaz:
https://doaj.org/article/8100c91d399d4f45b5b1de8bba5e2f24
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 47, Iss 1, Pp 3180-3187 (2019)
PAX8 is identified as a regulator in the pathogenesis of human tumours and an indicator of the prognosis for patients. However, the role of PAX8 on proliferation in gastric cancer have not been studied. This study was aimed to explore the expression
Externí odkaz:
https://doaj.org/article/a74fa62bf3b44cd2b5ab7238e6e9c3e0
Publikováno v:
BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background PAX8 was not only a mitotic factor, but identified as a transcription factor involved in the prognosis of human tumor patients. Elucidating the function of PAX8 on the pathology of stomach cancer was meaningful. Results PAX8 was f
Externí odkaz:
https://doaj.org/article/83f0a35b75ef4f32aaba6834508059f9
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 5, Iss 3, Pp 197-202 (2019)
Objective: Liver cancer is one of the most common types of cancer. We aimed to use the cancer registration data in 2015 to estimate the incidence and mortality of liver cancer in Henan province. Methods: The data from 37 population-based cancer regis
Externí odkaz:
https://doaj.org/article/41e136be5d394472b28b65ba70d22143
Autor:
Liang-Yu Bie, Dan Li, Yu Mu, Sheng Wang, Bei-Bei Chen, Hui-Fang Lyu, Li-Li Han, Cai-Yun Nie, Chang-Cheng Yang, Lin Wang, Chuan-Chuan Ren, Wei-Jie Zhang, Ping Guo, Feng Shi, Qing-Xia Fan, Liu-Xing Wang, Xiao-Bing Chen, Su-Xia Luo
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 5, Iss 1, Pp 44-52 (2019)
Objective: To explore genes potentially co-expressed with cyclin E in gastric cancer and discover possible targets for gastric cancer treatment. Methods: The Cancer Genome Atlas (TCGA) stomach adenocarcinoma sequencing data were used to predict genes
Externí odkaz:
https://doaj.org/article/35e896724d9748c68bcfb80d85929713
Publikováno v:
BMC Molecular and Cell Biology, Vol 22, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/a4eeca9c1e9e415f89a09354ed8ae547
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 1, Iss 3, Pp 158-162 (2015)
Objectives: To observe the curative effects and adverse reactions of recombinant human (rh)-endostatin injection combined with a TP regimen for treating patients with advanced ovarian cancer. Methods: Fifty-four patients with pathologically confirmed
Externí odkaz:
https://doaj.org/article/d183f4d6e047450ab73acaff46931f5f
Autor:
Ning Li, Zhi Li, Qiang Fu, Bin Zhang, Jian Zhang, Xiang-Bin Wan, Chao-Min Lu, Jin-Bang Wang, Wen-Ying Deng, Yi-Jie Ma, Liang-Yu Bie, Meng-Yu Wang, Jing Li, Qing-Xin Xia, Chen Wei, Su-Xia Luo
Publikováno v:
International Journal of Surgery; Apr2024, Vol. 110 Issue 4, p2071-2084, 14p
Autor:
Fangkun Li, Lin Zheng, Yan Zhao, Jinhua Huang, Hailiang Li, Su-Xia Luo, J.H. Shin, Chen-Yang Guo
Publikováno v:
Journal of Interventional Medicine
Journal of Interventional Medicine, Vol 4, Iss 1, Pp 39-45 (2021)
Journal of Interventional Medicine, Vol 4, Iss 1, Pp 39-45 (2021)
Objective: To explore the clinical significance of serum midkine (MDK) levels for the diagnosis of hepatocellular carcinoma (HCC) and evaluate the efficacy of interventional therapy. Methods: Eighty-four patients with HCC were enrolled in this retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a8fca2c3b93fa9940ec1928989efed
https://doi.org/10.1016/j.jimed.2020.10.009
https://doi.org/10.1016/j.jimed.2020.10.009